EXASEXACT SCIENCES CORP

Nasdaq exactsciences.com


$ 62.08 $ 1.53 (2.53 %)    

Friday, 03-May-2024 15:59:57 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 62.07
$ 62.62
$ 0.00 x 0
$ 0.00 x 0
$ 61.46 - $ 63.98
$ 56.05 - $ 100.77
1,612,633
na
11.18B
$ 1.19
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-21-2024 12-31-2023 10-K
2 11-01-2023 09-30-2023 10-Q
3 08-01-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 02-21-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-02-2022 06-30-2022 10-Q
8 04-26-2022 03-31-2022 10-Q
9 02-22-2022 12-31-2021 10-K
10 11-02-2021 09-30-2021 10-Q
11 07-28-2021 06-30-2021 10-Q
12 05-04-2021 03-31-2021 10-Q
13 02-16-2021 12-31-2020 10-K
14 10-27-2020 09-30-2020 10-Q
15 07-31-2020 06-30-2020 10-Q
16 05-06-2020 03-31-2020 10-Q
17 02-21-2020 12-31-2019 10-K
18 10-30-2019 09-30-2019 10-Q
19 07-30-2019 06-30-2019 10-Q
20 04-30-2019 03-31-2019 10-Q
21 02-21-2019 12-31-2018 10-K
22 10-30-2018 09-30-2018 10-Q
23 08-01-2018 06-30-2018 10-Q
24 04-26-2018 03-31-2018 10-Q
25 02-22-2018 12-31-2017 10-K
26 10-30-2017 09-30-2017 10-Q
27 07-25-2017 06-30-2017 10-Q
28 04-27-2017 03-31-2017 10-Q
29 02-21-2017 12-31-2016 10-K
30 10-26-2016 09-30-2016 10-Q
31 07-26-2016 06-30-2016 10-Q
32 05-03-2016 03-31-2016 10-Q
33 02-24-2016 12-31-2015 10-K
34 10-30-2015 09-30-2015 10-Q
35 07-31-2015 06-30-2015 10-Q
36 05-04-2015 03-31-2015 10-Q
37 02-27-2015 12-31-2014 10-K
38 10-31-2014 09-30-2014 10-Q
39 08-01-2014 06-30-2014 10-Q
40 05-02-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 exact-sciences-appoints-aaron-bloomer-as-cfo-effective-may-15-2024

To help facilitate a smooth transition, Bloomer joins the company as executive vice president, finance, effective immediately, ...

 exact-sciences-announces-debt-exchange-transaction-and-private-placement-of-convertible-senior-notes

On April 10, 2024 it entered into privately negotiated exchange and purchase agreements (the "Agreements") with certain...

 exact-sciences-to-present-late-breaking-data-from-ascend-2-study-validating-its-investigational-multi-cancer-early-detection-test-at-aacr-annual-meeting-2024

First analysis from ASCEND-2 confirms high detection rates and specificity achieved with multi-biomarker approach in most aggre...

 exact-sciences-launches-initiative-with-mayo-clinic-to-provide-comprehensive-genomic-profiling-and-hereditary-cancer-tests-to-patients

The initiative expands the collection of data accessible to Mayo Clinic researchers and clinicians to advance cancer research a...

 citigroup-maintains-buy-on-exact-sciences-announces-100-price-target

Citigroup analyst Patrick Donnelly maintains Exact Sciences (NASDAQ:EXAS) with a Buy and announces $100 price target.

 championx-montrose-environmental-group-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were lower, with the Dow Jones falling around 400 points on Tuesday.

 rex-american-resources-reports-upbeat-earnings-joins-avalo-therapeutics-rh-and-other-big-stocks-moving-higher-on-thursday

U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corpo...

 canaccord-genuity-maintains-buy-on-exact-sciences-lowers-price-target-to-90

Canaccord Genuity analyst Kyle Mikson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and lowers the price target from $10...

 nasdaq-sp-500-futures-jump-as-nvidia-surge-raises-fomo-rally-hopes-analyst-tells-why-jobs-data-holds-key-for-momentum

Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speech...

 exact-sciences-sees-fy24-revenue-281b-285b-vs-283b-est

2024 revenue outlookThe company anticipates revenue of $2.810-$2.850 billion during 2024, assuming:Screening revenue of $2.155-...

 exact-sciences-q4-eps-027-beats-046-estimate-sales-64688m-beat-63722m-estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.46...

 wall-street-waits-with-bated-breath-for-nvidia-earnings-after-tech-selloff-fed-minutes-eyed-analyst-flags-this-as-biggest-risk-for-market

The market will broaden the sustenance of its rally when interest-rate cuts begin to be priced in and investors begin to think ...

 earnings-scheduled-for-february-21-2024

Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION